A real-world study of the safety and efficacy of Ganmaoling granules (999) in the treatment of the common cold
Phase 4
Recruiting
- Conditions
- common cold
- Registration Number
- ITMCTR2000002998
- Lead Sponsor
- China-Japan Friendship Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Clinically diagnosed as common cold;
2. Aged >=18 years old;
3. This prescription contains Ganmaoling granules (999) or any of the following western medicine compound preparations: meipu pseudotablet, compound aminophenol pseudotablet sustained release capsule, pseudoaminophenol pseudoamefen tablet, aminophenemide tablet, compound aminophenolamine tablet (capsule), phenolcahuang capsule;
4. Participate in this study voluntarily and sign the informed consent.
Exclusion Criteria
1. Failure to cooperate to complete information collection;
2. The researcher considers it inappropriate to participate in this study.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complication rate;Drug combination;effective rate;symptom score;ADR;AE;
- Secondary Outcome Measures
Name Time Method